- Report
- August 2024
- 140 Pages
Global
From €2729EUR$2,999USD£2,340GBP
- Report
- August 2024
- 138 Pages
Global
From €2729EUR$2,999USD£2,340GBP
- Report
- August 2024
- 135 Pages
Global
From €2729EUR$2,999USD£2,340GBP
- Report
- August 2024
- 137 Pages
Global
From €2729EUR$2,999USD£2,340GBP
- Report
- August 2024
- 136 Pages
Global
From €2729EUR$2,999USD£2,340GBP
- Report
- August 2024
- 137 Pages
Global
From €2729EUR$2,999USD£2,340GBP
- Report
- April 2025
- 135 Pages
Global
From €2729EUR$2,999USD£2,340GBP
- Report
- April 2025
- 144 Pages
Global
From €2729EUR$2,999USD£2,340GBP
- Report
- April 2025
- 149 Pages
Global
From €2729EUR$2,999USD£2,340GBP
- Report
- April 2025
- 147 Pages
Global
From €2729EUR$2,999USD£2,340GBP
- Report
- February 2025
- 143 Pages
Global
From €2729EUR$2,999USD£2,340GBP
- Report
- January 2025
- 129 Pages
Global
From €2729EUR$2,999USD£2,340GBP
- Report
- January 2025
- 123 Pages
Global
From €2729EUR$2,999USD£2,340GBP
- Report
- January 2025
- 125 Pages
Global
From €2729EUR$2,999USD£2,340GBP
- Report
- August 2024
- 149 Pages
Global
From €2729EUR$2,999USD£2,340GBP
- Report
- August 2024
- 137 Pages
Global
From €2729EUR$2,999USD£2,340GBP
- Report
- August 2024
- 143 Pages
Global
From €2729EUR$2,999USD£2,340GBP
- Report
- July 2024
- 148 Pages
Global
From €2729EUR$2,999USD£2,340GBP
- Report
- July 2024
- 168 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Report
- July 2024
- 190 Pages
Global
From €4323EUR$4,750USD£3,706GBP

The biopharmaceuticals market is a sector of the pharmaceutical industry that focuses on the development and production of drugs derived from biological sources. These drugs are typically produced using recombinant DNA technology, which involves the manipulation of genetic material to create proteins and other molecules with therapeutic properties. Biopharmaceuticals are used to treat a wide range of diseases, including cancer, HIV/AIDS, and autoimmune disorders.
Biopharmaceuticals are typically more expensive to produce than traditional pharmaceuticals, but they offer a number of advantages, such as improved efficacy and fewer side effects. They are also more targeted, meaning they can be used to treat specific conditions more effectively.
Some of the major companies in the biopharmaceuticals market include Amgen, Biogen, Celgene, Gilead Sciences, and Novartis. These companies are involved in the development and production of a wide range of biopharmaceuticals, including monoclonal antibodies, vaccines, and gene therapies. Show Less Read more